Delta-Fly Pharma, Inc.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (9)
Delta-Fly Pharma, Inc. made a loss over the last year. Delta-Fly Pharma, Inc. owes ¥0.86 for every ¥1 it owns. Delta-Fly Pharma, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in Japan · latest annual results Mar 2026.
P/E ratio
LossDelta-Fly Pharma, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
30.14The share price is 30.14 times Delta-Fly Pharma, Inc.'s book value per share, higher than almost all Healthcare companies in Japan.
Market cap
¥1.0 BThe total market value of all of Delta-Fly Pharma, Inc.'s shares at today's price (share price × number of shares), smaller than almost all Healthcare companies in Japan. PosiCap size class: Nano Cap.
Net worth (book value)
¥34 MWhat Delta-Fly Pharma, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
¥2.39Net worth divided by the number of shares. The share price of ¥72.00 is 30.1 times this, which is the P/B above.
Return on equity (ROE)
-736.8%Delta-Fly Pharma, Inc. lost 736.8% of its shareholders' money over the last year, lower than almost all Healthcare companies in Japan.
Owes vs Owns
0.86×Delta-Fly Pharma, Inc. owes ¥0.86 for every ¥1 it owns (high), higher than 96% of Healthcare companies in Japan.
Dividend yield
NoneDelta-Fly Pharma, Inc. does not currently pay a dividend.
Profit growth
LossDelta-Fly Pharma, Inc. made a loss in each of the last two years.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Delta-Fly Pharma, Inc.: ¥1.0 B ÷ ¥34 M (31 Mar 2026) = 30.1.
What is Delta-Fly Pharma, Inc.'s return on equity?
Delta-Fly Pharma, Inc. lost 736.8% of its shareholders' money over the last year, lower than almost all Healthcare companies in Japan.
How much does Delta-Fly Pharma, Inc. owe compared with what it owns?
Delta-Fly Pharma, Inc. owes ¥0.86 for every ¥1 it owns (high), higher than 96% of Healthcare companies in Japan.
Does Delta-Fly Pharma, Inc. pay a dividend?
No. Delta-Fly Pharma, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.